EMA Publishes “Biosimilar Friendly” Guidelines
The EMA has recently published guidelines for the development of monoclonal antibody-containing biosimilar products.
The EMA has recently published guidelines for the development of monoclonal antibody-containing biosimilar products.
BioPharm Int'l recently published a nice overview of where the FDA debate is on biosimilars. Highlights: There is broad support for legislation which clarifies the path for biosimilars to be…
The Indian pharmaceutical market is highly fragmented. How can pharma companies make money? PharmaTimes characterizes the market for us in summary form.
PharmaPhorum has an excellent analysis on launch evolution across pharmerging markets, such as China, Brazil, Russia, and so forth. A few items of note: 1. The author projects that by…
Today we learn that Lilly is acquiring Avid Radiopharmaceuticals: Lilly will acquire all outstanding shares of Avid for an upfront payment of $300 million, subject to adjustment based on existing cash on…